Berkshire Bank’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
Berkshire Bank's PFE Position: Q2 2026 in Review
Berkshire Bank reduced its Pfizer (PFE) stake by 14% in Q2 2026, selling an estimated $58.8K and leaving 14,302 shares worth $344K. The position accounts for 0.07% of the portfolio, ranked #123.
Berkshire Bank first reported a position in PFE in Q3 2020 and has held it in 24 quarters since. The position peaked at $4.98M in Q4 2021. 1,377 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Berkshire Bank held 14,302 shares of Pfizer worth $344K as of Q2 2026.
- Berkshire Bank sold 2,249 Pfizer shares in Q2 2026, an estimated $58.8K.
- Pfizer made up 0.07% of Berkshire Bank's portfolio in Q2 2026, its #123 holding.
- Berkshire Bank first reported a position in Pfizer in Q3 2020 and has held it in 24 quarters since.
- Berkshire Bank's Pfizer position peaked at $4.98M in Q4 2021.
- 1,377 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Berkshire Bank's 13F filing for Q2 2026, filed 8 Jul 2026.